Skip to content

the Effectiveness of Therapeutic Virtual Reality Versus Pharmacological Sedation on Pain and Anxiety During Interventional Cardiology Procedures

Prospective Randomized Comparative Study Evaluating the Efficacy of Therapeutic Virtual Reality Versus Pharmacological Sedation on Pain and Anxiety During Interventional Cardiology Procedures

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05588232
Acronym
VirtuCardio
Enrollment
136
Registered
2022-10-20
Start date
2021-10-18
Completion date
2022-02-24
Last updated
2022-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Angiography, Coronarography, Drug Sedation, Virtual Reality

Brief summary

Immersion sedation in virtual reality could be an alternative to conventional pharmacological sedation, during interventional cardiology acts on pain and anxiety control. The objective of this study is to determine whether virtual reality immersion is non-inferior to drug sedation on pain and anxiety, during coronary angiography or angioplasty.

Interventions

PROCEDUREscheduled outpatient interventions in interventional cardiology

coronary angiography, coronary angioplasty, peripheral angioplasty (carotid arteries or lower limbs)

Sponsors

Elsan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Intervention model description

Monocentric, prospective, comparative, randomized, open-label study.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patient * who must benefit from one of the following scheduled interventional cardiology outpatient procedures: coronary angiography, coronary angioplasty, peripheral angioplasty (lower limbs) * Affiliation to a social security scheme or beneficiary of such a scheme. * Patient having signed the free and informed consent

Exclusion criteria

* Dementia * Language barrier * Claustrophobia * Nausea * History of intolerance to Virtual Reality * Patient with epilepsy * Refusal to participate in the study * Protected patient: minor, adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision * Pregnant, breastfeeding or parturient woman * Unstable patient (state of shock, respiratory or neurological distress)

Design outcomes

Primary

MeasureTime frameDescription
Maximum pain during the interventional cardiology procedures1 daymeasured on a scale of 0 to 10.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026